Hypertensive Heart Disease
17
2
3
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.9%
1 terminated out of 17 trials
90.0%
+3.5% vs benchmark
6%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Polyamine Treatment in Elderly Patients With Coronary Artery Disease
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Role of ARNi in Ventricular Remodeling in Hypertensive LVH
Hypertensive Heart Disease in DR Congo
Impact of Renal Denervation in Patients With Coronary Microvascular Dysfunction: Study Design and Rationale
Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection
Differentiation HHD From HCM (EARLY-MYO-HHD)
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study
The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia
Sympathetic Activity and Cardiometabolic Complications
Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet in Diastolic Heart Failure
Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2)
E_Stethoscope: Portable Digital Auscultation Study on Hypertensive/Hypertensive Heart Disease Patients
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
Asian American Partnerships in Research and Empowerment (AsPIRE)
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan